Check out our last systematic review and meta-analysis: #polypharmacy is common in #prefrail and #frail persons, which are also more likely to be on extreme drug regimens. #frailty #geriatrics #lessismore @GrazianoOnder @MirkoPe41401841 @EuGMSSociety h
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
RT @danisevisan: "Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.c…
"Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis" https://t.co/uqbUo8ll0c